{
    "code": "02015522",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02015522",
    "time": "2020-02-25 11:01:27",
    "許可證字號": "衛署藥輸字第015522號",
    "註銷狀態": "已註銷",
    "註銷日期": "80\/08\/28",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "81\/04\/18",
    "發證日期": "75\/12\/01",
    "許可證種類": "製　劑",
    "舊證字號": "02003417",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201552202",
    "中文品名": "倍利林注射液１０００單位\/公撮",
    "英文品名": "HEPARIN SODIUM INJECTION 1,000UNIT\/ML.",
    "適應症": "血栓性栓塞症及其預防、抗凝血",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "HEPARIN",
    "限制項目": "02輸　入",
    "申請商名稱": "1213201100  雄恆行股份有限公司",
    "申請商地址": "台北巿民權東路三段５８號八樓",
    "主製造廠": [
        {
            "製造廠名稱": "FGB0037000  EVANS MEDICAL LTD.",
            "製造廠廠址": "SPEKE LIVERPOOL L24 9DJLANGHURST HORSHAM, WEST SUSSEX. RH134QD, ENGLAND",
            "製造廠公司地址": "LANGHURST HORSHAM, WEST SUSSEX. RH134QD, ENGLAND",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012400500",
            "成分名稱": "HEPARIN",
            "含量描述": "1000",
            "含量": "1000.0000000000",
            "單位": "U (UN"
        }
    ]
}